USA - NASDAQ:KPRX - US49721T5074 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to KPRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-07-23 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2024-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2024-02-09 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-08-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-08-09 | Maxim Group | Maintains | Buy -> Buy | 
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-03-24 | HC Wainwright & Co. | Reiterate | Buy | 
| 2023-02-09 | Maxim Group | Upgrade | Hold -> Buy | 
| 2023-02-08 | Ladenburg Thalmann | Reiterate | Buy | 
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy | 
| 2022-08-25 | Ladenburg Thalmann | Initiate | Buy | 
| 2022-08-15 | Maxim Group | Downgrade | Buy -> Hold | 
| 2022-07-11 | HC Wainwright & Co. | Maintains | Buy | 
| 2022-04-19 | HC Wainwright & Co. | Maintains | Buy | 
| 2022-01-19 | Maxim Group | Initiate | Buy | 
8 analysts have analysed KPRX and the average price target is 11.22 USD. This implies a price increase of 340% is expected in the next year compared to the current price of 2.55.
The consensus rating for KIORA PHARMACEUTICALS INC (KPRX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering KIORA PHARMACEUTICALS INC (KPRX) is 8.